Skip to main content
logo
Sun Pharmaceutical Industries Limited (BOM:524715)
India flag India · Delayed Price · Currency is INR
1,634.40
+21.85 (1.35%)
At close: Jan 22, 2026

BOM:524715 Revenue

Sun Pharmaceutical Industries had revenue of 144.78B INR in the quarter ending September 30, 2025, with 8.93% growth. This brings the company's revenue in the last twelve months to 549.64B, up 9.26% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B with 8.42% growth.

Revenue (ttm)
549.64B
Revenue Growth
+9.26%
P/S Ratio
7.13
Revenue / Employee
12.78M
Employees
43,000
Market Cap
3.92T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025525.78B40.82B8.42%
Mar 31, 2024484.97B46.11B10.51%
Mar 31, 2023438.86B52.31B13.53%
Mar 31, 2022386.54B51.56B15.39%
Mar 31, 2021334.98B6.61B2.01%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Dr. Reddy's Laboratories345.83B
Lupin247.51B
Torrent Pharmaceuticals122.48B
Jubilant Pharmova76.18B
Abbott India67.14B
Granules India48.42B
J. B. Chemicals & Pharmaceuticals41.93B
GlaxoSmithKline Pharmaceuticals37.09B
Revenue Rankings

Sun Pharmaceutical Industries News

More News